EX VIVO GAMMA DELTA T CELL POPULATIONS

The invention relates to ex vivo methods of modulating Vd1 T cells using anti-Vd1 antibodies or fragments thereof. L'invention concerne des procédés ex vivo de modulation de lymphocytes Vd1 T à l'aide d'anticorps anti-Vd1 ou de fragments de ceux-ci.

Saved in:
Bibliographic Details
Main Authors BERGERHOFF, KATHARINA, NUSSBAUMER, OLIVER, POLYAKOVA, OXANA
Format Patent
LanguageEnglish
French
Published 25.02.2021
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The invention relates to ex vivo methods of modulating Vd1 T cells using anti-Vd1 antibodies or fragments thereof. L'invention concerne des procédés ex vivo de modulation de lymphocytes Vd1 T à l'aide d'anticorps anti-Vd1 ou de fragments de ceux-ci.
Bibliography:Application Number: CA20203148588